Modifying cancer risk through diet Diet represents an increasingly significant risk factor for a variety of cancers, but it is a risk that patients can modify with help from their GPs.
PBAC approval of HIV drug a major step forward for at-risk populations The recent Pharmaceutical Benefits Advisory Committee approval of a ground-breaking HIV drug will allow men who have sex with men to retain control over their own sexual health, GP and sexual health advocate Dr George Forgan-Smith told newsGP.
Key updates to colorectal cancer clinical practice guidelines There are three important changes for GPs and their patients in the updated guidelines for colorectal cancer screening.
GP suggests caution for new cancer detection blood test A new blood test may offer the possibility of early cancer detection in primary care – although it is still too early to be certain.
New test kit available for the National Bowel Cancer Screening Program The Department of Health has introduced a new test kit as part of the National Bowel Cancer Screening Program.
Almost 40% of Australian cancer deaths could be avoided with lifestyle changes New research showing almost 40% of Australian cancer deaths could be avoided with lifestyle changes helps to underline the importance of preventive healthcare.
What GPs need to know about the renewed National Cervical Screening Program Dr Lara Roeske, GP and cervical cancer screening expert, writes for newsGP about the coming changes to the renewed National Cervical Screening Program.
New site collates cancer data from across Australia Cancer Australia’s new interactive website is designed to provide healthcare professionals and patients with ‘national data across the continuum of cancer control’.
New Cancer Australia guide for GPs on investigation of breast symptoms Cancer Australia’s new Investigation of a new breast symptom: A guide for general practitioners has been developed in recognition of the vital role GPs play in the assessment of possible breast cancer symptoms.
Clinical Pearl: Osteoporosis and breast cancer Bone health is of paramount importance for patients undergoing aromatase inhibitor (AI) therapy for breast cancer. While endocrine treatments improve cancer-specific outcomes, they may cause severe hypogonadism leading to accelerated bone loss.